Anthony Taparo - Mar 13, 2023 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Growth Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Stock symbol
SGRY
Transactions as of
Mar 13, 2023
Transactions value $
-$172,893
Form type
4
Date filed
3/15/2023, 05:21 PM
Previous filing
Mar 6, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale -$45.4K -1.51K -1.49% $30.09 99.9K Mar 13, 2023 Direct F1, F2
transaction SGRY Common Stock Sale -$127K -4.07K -4.07% $31.11 95.8K Mar 14, 2023 Direct F2, F3
transaction SGRY Common Stock Sale -$963 -32 -0.03% $30.10 95.8K Mar 15, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 10, 2023 and March 11, 2023.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2023.